alexa Toshihiro Shirai
ISSN: 2155-6121

Journal of Allergy & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Toshihiro Shirai

Toshihiro Shirai Early Biomarker for Treatment Study Group, Innovative Asthma Association, Japan

Toshihiro Shirai serves as Early Biomarker for Treatment Study Group, Innovative Asthma Association, Japan Dr. Toshihiro's particularly interested inAsthma, and has authored and co-authored 1000 academic publications indexed in pubmed for international journals and conferences.

Research Interest

Exhaled Nitric Oxide Measurement may Predict Asthma Exacerbation after Stepping down Formoterol/Budesonide Combination Therapy in Adult Asthma

Toshihiro Shirai, Tomotaka Kawayama, Hiroyuki Nagase, Hiromasa Inoue, Suguru Sato, Koichiro Asano and Hiroaki Kume

Research Article: J Allergy Ther 2014, 5:173

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version